Maze Therapeutics (MAZE) Other Non-Current Liabilities (2024 - 2026)

Maze Therapeutics (MAZE) has 3 years of Other Non-Current Liabilities data on file, last reported at $388000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities fell 61.43% year-over-year to $388000.0; the trailing twelve-month figure through Mar 2026 stood at $388000.0 (down 61.43% YoY), and the FY2025 full-year result was $1.1 million, up 12.9% from the prior year.
• Other Non-Current Liabilities declined to $388000.0 in Q1 2026, from $1.1 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $1.1 million in Q4 2025 to a low of $388000.0 in Q1 2026.
• A 3-year average of $939666.7 and a median of $1.0 million in 2025 frame the typical range for Other Non-Current Liabilities.
• Across the five-year window, Other Non-Current Liabilities gained 12.9% in 2025 and tumbled 61.43% in 2026, its largest moves.
• Tracing MAZE's Other Non-Current Liabilities over 3 years: stood at $969000.0 in 2024, then grew by 12.9% to $1.1 million in 2025, then sank by 64.53% to $388000.0 in 2026.
• Business Quant data shows MAZE's Other Non-Current Liabilities at $388000.0 in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.